3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Pro Medicus shines as a top-tier choice with its robust business model, high margins, and the increasing global demand for its cutting-edge medical imaging technology.
  • REA Group's dominance as the go-to platform for property dealings and its smart diversification strategy position it well to capitalise on Australia's burgeoning digital services sector.
  • Temple & Webster is set to benefit from the shift towards online shopping, leveraging its efficient business model and market growth opportunities within the furniture sector.

Trying to predict what the share market will do next month or next year is a tough game. But looking a decade ahead is where long-term investors often gain a real edge.

Businesses with sustainable competitive advantages, long growth runways, and proven execution can compound shareholder value quietly over many years.

If you are prepared to buy quality and sit tight through market cycles, the rewards by 2035 could be substantial.

With that in mind, here are three Australian shares that tick those boxes and look well placed for long-term buy and hold investors.

woman looking at iPhone whilst working on a laptop

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus is arguably one of the ASX's highest-quality companies. It is the medical imaging software provider behind the Visage platform, which is used by leading hospitals and health networks across the United States.

What makes Pro Medicus especially attractive as a long-term holding is the strength of its business model. It operates with exceptionally high margins, recurring revenue, and minimal capital requirements. Once a hospital adopts its Visage platform, switching costs are high, and contract lengths are long.

With global demand for medical imaging continuing to rise due to radiologist shortages and digitisation still in its early stages, Pro Medicus has a long runway to expand earnings well beyond the next decade.

REA Group Ltd (ASX: REA)

REA Group is the company behind the realestate.com.au website. It has become the default destination for Australian property buyers, sellers, and agents, giving the company immense pricing power.

Even during softer housing markets, REA has continued to grow earnings by lifting yields from agents and expanding into adjacent services such as data, mortgages, and commercial property listings. This ability to grow without relying solely on listings volumes is a key reason it has been such a strong long-term performer.

Looking ahead to 2035, Australia's population growth, housing undersupply, and ongoing shift toward digital services suggest REA's competitive position is unlikely to weaken anytime soon. This bodes well for its earnings growth over the next decade.

Temple & Webster Group Ltd (ASX: TPW)

Finally, Temple & Webster may not yet have the scale of the other two, but its long-term potential is compelling. The online furniture and homewares retailer has steadily taken market share as consumers shift away from traditional bricks-and-mortar stores.

Its asset-light, digital-first model allows it to offer a wider product range, better data-driven marketing, and lower overheads than many competitors. Importantly, online penetration in furniture remains relatively low compared to categories like electronics or apparel, leaving plenty of room for growth.

If Temple & Webster continues to execute well, expands its private label offering, and benefits from the ongoing e-commerce tailwind, the next decade could be very positive.

Motley Fool contributor James Mickleboro has positions in Pro Medicus, REA Group, and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Growth Shares

What are the best ASX 200 shares to consider buying for the next 5 years?

Analysts have buy ratings on these quality shares for good reason.

Read more »

Two plants grow in jars filled with coins.
Growth Shares

Experts like this ASX share which expects to grow its profit by at least 20% this year!

This business has a lot of potential for earnings growth.

Read more »

Businessman takes off with rockets under his feet.
Growth Shares

2 ASX growth shares tipped to double in value

Despite sharp share price pullbacks, their long-term growth stories remain intact.

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Growth Shares

2 ASX growth stocks to buy now and hold for 10 years

These stocks could be destined for very bright futures in the age of AI.

Read more »

A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
Growth Shares

$10,000 invested in Droneshield and Woodside shares just 1 week ago is now worth…

And here's what the analysts expect from these two ASX 200 stocks next.

Read more »

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Growth Shares

3 lesser-known ASX shares making investors an outrageous amount of money

And there could be a lot more upside to come.

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Growth Shares

2 of the best ASX growth shares to buy now

Analysts at Morgans have named these shares as best buys for growth investors.

Read more »

Man sits smiling at a computer showing graphs.
Growth Shares

Where I'd invest $10,000 in ASX growth shares right now

These 3 companies combine proven technology with strong growth prospects and global expansion potential.

Read more »